Compare ANAB & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANAB | DSGR |
|---|---|---|
| Founded | 2005 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2015 | 1995 |
| Metric | ANAB | DSGR |
|---|---|---|
| Price | $62.39 | $27.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $71.67 | $35.00 |
| AVG Volume (30 Days) | ★ 570.6K | 58.8K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 91.02 | ★ 212.50 |
| EPS | N/A | ★ 0.01 |
| Revenue | $234,603,000.00 | ★ $1,980,023,000.00 |
| Revenue This Year | N/A | $5.35 |
| Revenue Next Year | $52.14 | $3.79 |
| P/E Ratio | ★ N/A | $2,720.00 |
| Revenue Growth | ★ 157.01 | 9.75 |
| 52 Week Low | $17.11 | $19.02 |
| 52 Week High | $73.30 | $33.80 |
| Indicator | ANAB | DSGR |
|---|---|---|
| Relative Strength Index (RSI) | 56.57 | 46.04 |
| Support Level | $52.32 | $26.98 |
| Resistance Level | $67.69 | $28.03 |
| Average True Range (ATR) | 3.27 | 0.72 |
| MACD | 0.87 | -0.09 |
| Stochastic Oscillator | 54.78 | 17.50 |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Distribution Solutions Group Inc is a specialty distribution company providing value-added distribution solutions to the maintenance, repair and operations (MRO), original equipment manufacturer (OEM) and industrial technology markets. The company operates through four reportable segments: Lawson, TestEquity, Gexpro Services and Canada Branch Division. Lawson distributes specialty products and services to the industrial, commercial, institutional and government MRO marketplace. TestEquity, which generates maximum revenue, distributes test and measurement equipment and solutions, industrial and electronic production supplies and vendor managed inventory programs. Gexpro Services is a supply chain solutions provider. The company generates majority of its revenue from United States.